New products
SetPoint treats first patient with neuroimmune modulation system
SetPoint Medical treated its first patient with the SetPoint neuroimmune modulation system at Beth Israel Deaconess Medical Center in Boston. The therapy represents a clinical milestone for the company's approach to modulating immune response through neural mechanisms. Further details on efficacy endpoints and regulatory pathway were not provided in the announcement.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network